Lagis Enterprise Co., Ltd., a medical device development company, develops and markets medical devices for the laparoscopic and endoscopic surgical markets worldwide. More Details
Flawless balance sheet unattractive dividend payer.
Share Price & News
How has Lagis Enterprise's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 6730 is less volatile than 75% of TW stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: 6730's weekly volatility (4%) has been stable over the past year.
7 Day Return
TW Medical Equipment
1 Year Return
TW Medical Equipment
Return vs Industry: 6730 underperformed the TW Medical Equipment industry which returned -5.1% over the past year.
Return vs Market: 6730 underperformed the TW Market which returned 48.5% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Lagis Enterprise's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 months ago | Simply Wall StBe Wary Of Lagis Enterprise (GTSM:6730) And Its Returns On Capital
4 months ago | Simply Wall StAre Lagis Enterprise Co., Ltd.'s (GTSM:6730) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
6 months ago | Simply Wall StFactors Income Investors Should Consider Before Adding Lagis Enterprise Co., Ltd. (GTSM:6730) To Their Portfolio
Is Lagis Enterprise undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 6730 (NT$38.15) is trading above our estimate of fair value (NT$17.19)
Significantly Below Fair Value: 6730 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 6730 is poor value based on its PE Ratio (37.8x) compared to the TW Medical Equipment industry average (20.1x).
PE vs Market: 6730 is poor value based on its PE Ratio (37.8x) compared to the TW market (17.6x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 6730's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 6730 is overvalued based on its PB Ratio (2.6x) compared to the TW Medical Equipment industry average (2.1x).
How is Lagis Enterprise forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Lagis Enterprise has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Lagis Enterprise performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 6730 has high quality earnings.
Growing Profit Margin: 6730's current net profit margins (10.1%) are lower than last year (21.9%).
Past Earnings Growth Analysis
Earnings Trend: 6730's earnings have declined by 10.2% per year over the past 5 years.
Accelerating Growth: 6730's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 6730 had negative earnings growth (-63.7%) over the past year, making it difficult to compare to the Medical Equipment industry average (9.9%).
Return on Equity
High ROE: 6730's Return on Equity (6.8%) is considered low.
How is Lagis Enterprise's financial position?
Financial Position Analysis
Short Term Liabilities: 6730's short term assets (NT$267.5M) exceed its short term liabilities (NT$65.8M).
Long Term Liabilities: 6730's short term assets (NT$267.5M) exceed its long term liabilities (NT$429.0K).
Debt to Equity History and Analysis
Debt Level: 6730 is debt free.
Reducing Debt: 6730 had no debt 5 years ago.
Debt Coverage: 6730 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 6730 has no debt, therefore coverage of interest payments is not a concern.
What is Lagis Enterprise current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 6730's dividend (2.1%) is higher than the bottom 25% of dividend payers in the TW market (2%).
High Dividend: 6730's dividend (2.1%) is low compared to the top 25% of dividend payers in the TW market (5.01%).
Stability and Growth of Payments
Stable Dividend: Too early to tell whether 6730's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if 6730's dividend payments are increasing as they only just started paying a dividend.
Current Payout to Shareholders
Dividend Coverage: At its current payout ratio (79.2%), 6730's payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Lagis Enterprise has no CEO, or we have no data on them.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Lagis Enterprise Co., Ltd.'s company bio, employee growth, exchange listings and data sources
- Name: Lagis Enterprise Co., Ltd.
- Ticker: 6730
- Exchange: TPEX
- Founded: 2004
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: NT$1.221b
- Shares outstanding: 32.00m
- Website: https://www.lagis.com.tw
Number of Employees
- Lagis Enterprise Co., Ltd.
- No.29, Gong 1st Road
Lagis Enterprise Co., Ltd., a medical device development company, develops and markets medical devices for the laparoscopic and endoscopic surgical markets worldwide. Its products include trocars, single p...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/06/17 23:10|
|End of Day Share Price||2021/06/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.